2003 May 16 | Kitt Falk Petersen, Douglas Befroy, Sylvie Dufour, James Dziura, Charlotte Ariyan, Douglas L. Rothman, Loretta DiPietro, Gary W. Cline, and Gerald I. Shulman
Mitochondrial dysfunction in the elderly may contribute to insulin resistance. A study compared healthy elderly and young individuals matched for lean body mass and fat mass. Elderly participants showed marked insulin resistance, primarily due to reduced insulin-stimulated muscle glucose metabolism. This was associated with increased fat accumulation in muscle and liver, as well as a 40% reduction in mitochondrial oxidative and phosphorylation activity. These findings support the hypothesis that age-related mitochondrial dysfunction contributes to insulin resistance in the elderly.
Type 2 diabetes is common in the elderly, affecting 30 million people over 65 in developed countries. Insulin resistance is a key factor in its development. The study found that elderly participants had higher plasma glucose and insulin levels during an oral glucose tolerance test, indicating insulin resistance. Hyperinsulinemic-euglycemic clamp studies showed that elderly participants required higher glucose infusion rates to maintain euglycemia, suggesting reduced insulin-stimulated glucose uptake in skeletal muscle.
The study also found increased intramyocellular and hepatic triglyceride content in elderly participants, possibly due to age-related mitochondrial dysfunction. In vivo measurements using 13C and 31P NMR spectroscopy showed reduced mitochondrial oxidative and phosphorylation activity in the elderly. These results suggest that age-related mitochondrial dysfunction may contribute to increased intramyocellular fatty acid metabolites, leading to insulin resistance.
The study also examined lipolysis and found that basal rates of whole-body glycerol turnover were similar in elderly and control participants. However, the results suggest that increased peripheral lipolysis and/or defects in insulin suppression of lipolysis may not be major factors in the increased intramyocellular and intrahepatic triglyceride content in the elderly.
The study concludes that mitochondrial dysfunction may play a significant role in the development of insulin resistance in the elderly, contributing to the high prevalence of type 2 diabetes in this population. The findings support the hypothesis that a decline in mitochondrial oxidative and phosphorylation energy production may also have an important role in aging.Mitochondrial dysfunction in the elderly may contribute to insulin resistance. A study compared healthy elderly and young individuals matched for lean body mass and fat mass. Elderly participants showed marked insulin resistance, primarily due to reduced insulin-stimulated muscle glucose metabolism. This was associated with increased fat accumulation in muscle and liver, as well as a 40% reduction in mitochondrial oxidative and phosphorylation activity. These findings support the hypothesis that age-related mitochondrial dysfunction contributes to insulin resistance in the elderly.
Type 2 diabetes is common in the elderly, affecting 30 million people over 65 in developed countries. Insulin resistance is a key factor in its development. The study found that elderly participants had higher plasma glucose and insulin levels during an oral glucose tolerance test, indicating insulin resistance. Hyperinsulinemic-euglycemic clamp studies showed that elderly participants required higher glucose infusion rates to maintain euglycemia, suggesting reduced insulin-stimulated glucose uptake in skeletal muscle.
The study also found increased intramyocellular and hepatic triglyceride content in elderly participants, possibly due to age-related mitochondrial dysfunction. In vivo measurements using 13C and 31P NMR spectroscopy showed reduced mitochondrial oxidative and phosphorylation activity in the elderly. These results suggest that age-related mitochondrial dysfunction may contribute to increased intramyocellular fatty acid metabolites, leading to insulin resistance.
The study also examined lipolysis and found that basal rates of whole-body glycerol turnover were similar in elderly and control participants. However, the results suggest that increased peripheral lipolysis and/or defects in insulin suppression of lipolysis may not be major factors in the increased intramyocellular and intrahepatic triglyceride content in the elderly.
The study concludes that mitochondrial dysfunction may play a significant role in the development of insulin resistance in the elderly, contributing to the high prevalence of type 2 diabetes in this population. The findings support the hypothesis that a decline in mitochondrial oxidative and phosphorylation energy production may also have an important role in aging.